Side Effects from Weight Loss Injections: What to Expect

Nausea, vomiting, diarrhoea and constipation are the most common side effects and typically ease as your body adjusts to each dose level.
The MHRA issued a Drug Safety Update in January 2026 specifically noting acute pancreatitis as an infrequent but potentially serious risk with GLP-1 medicines — severe stomach pain radiating to the back warrants urgent medical help.
These medicines slow gastric emptying, which underlies most of the GI side-effect profile; staying hydrated and eating smaller portions can reduce discomfort during the early weeks.
Suspected side effects (and any concerns about where a medicine came from) can be reported directly to the MHRA's Yellow Card scheme.

Most side effects from weight loss injections like Mounjaro (tirzepatide) and Wegovy (semaglutide) are gastrointestinal and settle within a week or two of starting or increasing a dose. Nausea is the most commonly reported; serious reactions are uncommon but real. These are prescription-only medicines — a clinician assesses whether they are right for you before anything is prescribed. This page covers what the evidence says, how to tell a tolerable side effect from one that needs urgent attention, and what decisions that leaves in your hands.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding your side-effect profile, and the decisions around managing it

The side effects most people actually experience

The honest picture is this: the majority of people taking a GLP-1 weight loss injection will notice some digestive disruption, particularly in the first few weeks or after a dose step up. The NHS patient information for tirzepatide lists nausea, vomiting, diarrhoea, constipation and indigestion as common. Headache, fatigue, dizziness and mild injection-site reactions also appear in the trial data. None of that is unusual for medicines that work by slowing gastric emptying and altering gut-hormone signalling.

What the trials showed is that these effects are typically front-loaded. They tend to peak shortly after starting or after a dose increase, then ease over several days to a fortnight. Eating smaller meals, avoiding high-fat foods during the early weeks, and keeping water within reach can all help. Some people also find keeping their pen in the same spot (the fridge door, say, where they'll see it each morning) builds the weekly routine that stops a dose being forgotten or delayed, which can itself trigger a return of early symptoms.

Injection-site reactions (redness, itching, a small lump) are usually minor and rotate away when you move between the abdomen, thigh and upper arm. For a fuller breakdown of individual symptoms and how common each one is, the full side-effect overview for weight loss injections goes into considerably more detail.

Side effects that call for urgent medical attention

This is the section worth reading carefully. Most side effects are uncomfortable rather than dangerous. A few are not.

Severe, persistent abdominal pain (especially if it spreads to the back, with or without vomiting) can be a sign of acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically flagging this risk for GLP-1 medicines. It is uncommon, but it can be serious. Do not wait it out: contact a GP or call 111, or go to A&E if the pain is severe.

Other symptoms that warrant prompt medical contact include: signs of a gallbladder problem (pain in the upper right abdomen, fever, jaundice); symptoms of significant dehydration from repeated vomiting or diarrhoea (very little urine, severe dizziness); any signs of an allergic reaction (swelling of the face, tongue or throat, difficulty breathing, widespread rash). Sudden changes in vision should also prompt a same-day call, particularly in people with diabetes-related eye conditions.

Low mood or thoughts of self-harm are listed in the safety data. They are rare, but if you notice a change in mood after starting treatment, speak to your GP. The guide to more serious side effects covers these signals with more detail, including when 111 is enough and when A&E is the right call.

Factors that shape how your body responds

Not everyone's side-effect profile looks the same. A few things influence it. Dose rate matters: people who titrate slowly tend to have fewer and milder symptoms than those who push up quickly. Whether someone eats a large, fatty meal right before or after the injection can amplify nausea. Alcohol can worsen GI symptoms and should be moderated, particularly early in treatment.

Certain health conditions affect how suitable these medicines are in the first place. A personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, a history of pancreatitis, and some gastrointestinal conditions are all factors a prescriber weighs before treatment starts. People with epilepsy managing their condition through medication may want to read specifically about interactions and GLP-1 treatment, as absorption changes during dose titration can have implications for other oral medicines.

That is the core of the clinical decision: the side-effect picture for you personally depends on your health history, your other medicines, and the dose schedule. Our prescribers at nume work through all of that as part of a consultation before anything is approved. If you are already on treatment elsewhere and want to switch, the same review applies.

What you can do, and what sits with your prescriber

There is plenty within your control. Eating slowly, keeping portions smaller than usual, choosing lower-fat meals, drinking water steadily through the day, all of these reduce the intensity of GI side effects for most people. Timing the injection to a day when you are not under particular pressure can also help, because nausea is less disruptive when you are not in a meeting or on a long car journey.

What is not in your hands is the dose schedule. Titration timing, decisions about staying on a dose longer than the standard four-week step, or any changes following a missed injection, those conversations belong with your prescriber. If you want to understand the full range of side effects of weight loss injections before your first dose, reading through that detail alongside the tirzepatide patient information leaflet and equivalent document for semaglutide is time well spent.

If you have questions about cost alongside safety, the cost page for weight loss injections explains what a legitimate private price includes. For a broader look at the options available, our treatment page sets out the full range and lets you start a free consultation with our prescribers, who discuss suitability and side effects as a standard part of every assessment.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions